Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
389
datasets available to search
ShareScore release 0.9.0
Dataset results
389 results for “Acute myeloid leukemia (AML)”
Vaccination With GM-K562 Cells in Patients With Advanced Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) After Allogeneic Hematopoetic Stem Cell Transplantation
ClinicalTrials.gov study NCT00809250. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of ASTX660 as a Single Agent and in Combination With ASTX727 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT04155580. IPD Sharing: NO. Countries: 1. Publications: 0.
Total Body Irradiation and Cladribine Before Allogeneic Hematopoietic Cell Transplantation in Patients With AML (Acute Myeloid Leukemia) and Myelodysplastic Syndromes
ClinicalTrials.gov study NCT04861207. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Pharmacokinetic and Efficacy Study of Amonafide L-malate (AS1413) in Combination With Cytarabine in Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01066494. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Anti-CLL1 CAR T-cell Therapy in CLL1 Positive Relapsed/Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT04884984. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05580601. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate Adverse Events and Movement of Intravenously (IV) Infused ABBV-787 in Adult Participants With Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT06068868. IPD Sharing: NO. Countries: 5. Publications: 0.
Phase I/II Study With Oral Panobinostat Maintenance Therapy Following Allogeneic Stem Cell Transplantation in Patients With High Risk Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01451268. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Non-interventional Ambispective Real-world Cohort of rEfractory and reLapsed (R/R) FLT3 Mutated Acute MyEloid Leukemia (AML) Patients Treated With Gilteritinib in FrANCE
ClinicalTrials.gov study NCT05193448. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of HYML-122 in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05241106. IPD Sharing: NO. Countries: 1. Publications: 0.
Healthcare Resource Utilization in Adults Diagnosed With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05488613. IPD Sharing: NO. Countries: 1. Publications: 0.
Elderly Patients With Acute Myeloid Leukemia (AML), Maintenance Phase After Complete Remission (CR)
ClinicalTrials.gov study NCT01301820. IPD Sharing: NO. Countries: 1. Publications: 0.
IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.
ClinicalTrials.gov study NCT06713837. IPD Sharing: NO. Countries: 7. Publications: 0.
Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Res
ClinicalTrials.gov study NCT06917911. IPD Sharing: YES. Countries: 0. Publications: 0.
CITE-seq (cellular indexing of transcriptomes and epitopes by sequencing) of WT and RAS mutant specimens from acute myeloid leukemia (AML) patients.
GEO Series GSE156041. Homo sapiens. 9 samples. Type: Expression profiling by high throughput sequencing.
Microarray analysis in acute myeloid leukemia (AML)-derived THP-1 cells expressing or not SAMHD1
GEO Series GSE113610. Homo sapiens. 6 samples. Type: Expression profiling by array.
D9, a novel 3-Deazaneplanocin A (DZNep) analog, is efficacious in targeting acute myeloid leukemia (AML) (Chemotherapy)
GEO Series GSE59625. Homo sapiens. 6 samples. Type: Expression profiling by array.
Analysis of methylation In childhood acute myeloid leukemia (AML)
GEO Series GSE124413. Homo sapiens. 500 samples. Type: Methylation profiling by array.
Improved Prediction of Venetoclax and Azacitidine Efficacy in Acute Myeloid Leukemia through Machine Learning [AML patients]
GEO Series GSE289786. Homo sapiens. 142 samples. Type: Expression profiling by high throughput sequencing.
Cdx2 driven acute myeloid leukemia is sensitive to therapy used in myeloid disease [RNASeq_Cdx2_AML_Azacitidine]
GEO Series GSE133680. Mus musculus. 9 samples. Type: Expression profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.